TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis

Published:2020-04-15 Issue:8 Volume:201 Page:946-954
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Danahay Henry L.¹,Lilley Sarah²,Fox Roy²,Charlton Holly²,Sabater Juan³,Button Brian⁴,McCarthy Clive¹,Collingwood Stephen P.¹,Gosling Martin¹²

Affiliation:

1. Enterprise Therapeutics, Brighton, United Kingdom

2. Sussex Drug Discovery Centre, University of Sussex, Brighton, United Kingdom

3. Mount Sinai Medical Center of Florida, Miami, Florida; and

4. Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference41 articles.

1. Cystic fibrosis

2. Origins of Cystic Fibrosis Lung Disease

3. Muco-Obstructive Lung Diseases

4. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure

5. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis;Nature Reviews Disease Primers;2024-08-08

2. TMEM16 proteins: Ca²⁺‑activated chloride channels and phospholipid scramblases as potential drug targets (Review);International Journal of Molecular Medicine;2024-07-29

3. Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial;Jornal Brasileiro de Pneumologia;2024-07-23

4. Anoctamin pharmacology;Cell Calcium;2024-07

5. Modulation of TMEM16B channel activity by the calcium-activated chloride channel regulator 4 (CLCA4) in human cells;Journal of Biological Chemistry;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3